IntraOp Medical Corporation Selects Affect Strategies as its Public Relations Agency of Record

IntraOp Medical Corporation Selects Affect Strategies as its Public Relations Agency of Record

Affect to help IntraOp raise awareness and drive demand for its innovative technology for the treatment and eradication of cancer

NEW YORK -- July 25, 2006 -- Affect Strategies, a public relations and strategic marketing firm, announced today that IntraOp Medical Corporation, provider of innovative technology solutions for the treatment and eradication of cancer, has selected the firm as its public relations agency of record. Affect will help IntraOp raise awareness and drive demand for the company's innovative technology solutions through a highly targeted and compelling public relations program.

IntraOp provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp has revolutionized the delivery of radiation-based cancer therapies. With over 200 years of cumulative experience in researching and developing groundbreaking cancer treatments, IntraOp is committed to providing the tools doctors need to administer radiation therapy safely and effectively - for all cancer patients.

As part of the new public relations campaign, Affect Strategies will develop strategic initiatives designed to heighten the media's awareness of IntraOp's medical technology and increase the recognition of intraoperative electron-beam radiation therapy (IOERT) as a viable cancer treatment. . Donald A. Goer, president and CEO of IntraOp Medical Corporation said, "IntraOp has already demonstrated success by providing cutting-edge cancer treatment solutions to leading disease treatment and medical research facilities around the world. We chose Affect Strategies because of the firm's proven successes, commitment to service excellence and results-oriented approach to business. Under the firm's guidance and direction, we believe we will be able to significantly raise awareness for our solutions and the importance of IOERT cancer treatment."

"With every client, we have a vested interest in their success," said Sandra Fathi, president of Affect Strategies. "With IntraOp, our zeal and passion are compounded because of the life-saving treatments the company offers. It is absolutely imperative for us to inform the medical community as well as the public about the advances in cancer treatment through the use of the Mobetron."

For more information on IntraOp, please visit www.intraopmedical.com.

About Affect Strategies

Affect Strategies is a public relations and strategic marketing firm located in New York. Established in 2002, the company combines strategy, creative and intelligent program development, impeccable execution and exemplary customer service to help its clients achieve their specific business goals. Specializing in technology and communications, Affect Strategies has also applied its marketing prowess to consumer goods and professional services. As year-round public relations counsel, or a single project resource, Affect leverages its business acumen and service excellence to achieve the precise results that its clients seek. For more information, please visit www.affectstrategies.com .For the company's blog, please visit www.techaffect.com.